Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to how human bodies detect and respond to viruses and viral replication.

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Cleveland Clinic virology researchers have found that a specific protein modification to the immune protein MDA5 is key to ...

Researchers had been studying the green alga Chlamydomonas reinhardtii for decades without seeing evidence of an active virus ...

Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that ...

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than ...

Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Hantaviruses can cause serious illnesses affecting the lungs and death. Rodents pass the virus through their droppings, urine and saliva.

GeneVentiv Therapeutics, a gene therapy company, today announced it has signed a global licensing agreement with Duke ...